S&P 500 Futures
(0.26%) 5 535.75 points
Dow Jones Futures
(0.27%) 39 574 points
Nasdaq Futures
(0.26%) 19 979 points
Oil
(0.63%) $82.05
Gas
(-1.73%) $2.56
Gold
(0.34%) $2 347.50
Silver
(0.14%) $29.60
Platinum
(-0.64%) $995.50
USD/EUR
(-0.26%) $0.931
USD/NOK
(-0.31%) $10.64
USD/GBP
(-0.18%) $0.789
USD/RUB
(2.09%) $87.52

Realaus laiko atnaujinimai Bio Rad Laboratories Inc [BIO]

Birža: NYSE Sektorius: Healthcare Pramonė: Medical - Devices
Atnaujinta28 birž. 2024 @ 23:00

0.41% $ 273.11

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.08% compare to its pairs and should correct upwards.
Profile picture for Bio Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America...

Stats
Šios dienos apimtis 428 327
Vidutinė apimtis 244 208
Rinkos kapitalizacija 7.81B
EPS $13.46 ( Q1 | 2024-05-08 )
Kita pelno data ( $2.12 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -25.55
(Sector) 49.64
(Industry) 37.79
ATR14 $0.296 (0.11%)
ABT -0.71%
ALUR -23.26%
AORT 3.22%
AVNS 1.63%
BFLY -3.33%
BFLY-WT 4.91%
BIO 0.41%
BIO-B 0.00%
BSX 0.01%
BSX-PA 2.37%
CATX 1.01%
CNMD 2.70%
CRY 1.42%
EW -1.04%
FNA 2.86%
GKOS 0.83%
GMED -0.52%
INSP -1.11%
ITGR 1.10%
MDT 0.10%
NVRO 0.72%
OWLT 6.46%
PEN 2.90%
PHG -1.87%
RBOT -15.78%
SNN 0.12%
SONX 0.00%
STE 1.43%
SYK 0.15%
VAPO -1.87%
ZBH 0.14%
Insider Trading
Date Person Action Amount type
2023-12-16 Wright Dara Buy 502 Bio-Rad A Common Stock
2023-12-16 Wright Dara Sell 174 Bio-Rad A Common Stock
2023-12-16 Wright Dara Sell 502 Restricted Stock Units
2023-12-05 Schwartz Steven D Buy 49 Bio-Rad B Common Stock
2023-12-05 Schwartz Steven D Buy 49 Bio-Rad B Common Stock
INSIDER POWER
-17.63
Last 100 transactions
Buy: 98 565 | Sell: 137 343
Koreliacija (AI algo v.1.1b): Undervalued: 0.08% $273.43 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.03 (neutral)
Trumpas: 0.56 (weak)
Signal:(74.674) Neutral

Bio Rad Laboratories Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RSF0.901
DLR-PJ0.887
PSA-PG0.887
HIO0.887
ATIP0.884
PSA-PF0.882
PSA-PR0.88
PSA-PS0.879
AMH-PG0.877
PSA-PJ0.876
10 Labiausiai neigiamai susiję koreliacijos
AIRC-0.921
ACB-0.868
CAG-0.836
WPM-0.835
DBB-0.834
SIL-0.833
FSM-0.83
ASA-0.82
MODN-0.811
CMCM-0.804

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bio Rad Laboratories Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.58
( weak negative )
The country flag -0.69
( moderate negative )
The country flag -0.62
( weak negative )
The country flag 0.22
( neutral )
The country flag 0.04
( neutral )
The country flag -0.71
( moderate negative )

Bio Rad Laboratories Inc Finansinės ataskaitos

Annual 2023
Pajamos: $2.67B
Bruto pelnas: $1.43B (53.58 %)
EPS: $-21.82
FY 2023
Pajamos: $2.67B
Bruto pelnas: $1.43B (53.58 %)
EPS: $-21.82
FY 2022
Pajamos: $2.80B
Bruto pelnas: $1.57B (55.93 %)
EPS: $-121.79
FY 2021
Pajamos: $2.92B
Bruto pelnas: $1.64B (56.14 %)
EPS: $142.63

Financial Reports:

No articles found.

Bio Rad Laboratories Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Bio Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 1.4892399311066 seconds
Number of API calls: 3
Number of DB calls: 9